Search
Login
Register
Menu
Last issue
Home
News
CongressUpdate
Guidelines
Specials
Links
Reimbursement News
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: Clinical implications of measurable residual disease in patients with AML
You cannot add another "Article: Highlights in gynaecological cancers" to your cart.
View cart
Article: Clinical implications of measurable residual disease in patients with AML
€
3.03
Article: Clinical implications of measurable residual disease in patients with AML quantity
Add to cart
SKU:
product-article-27296
Category:
General
Description
Description
Clinical implications of measurable residual disease in patients with AML
Related products
1 year access Online Belgian Journal of Hematology (BJH)
€
71.94
Add to cart
Article: Highlights in genitourinary cancers
€
3.03
Add to cart
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€
209.83
Add to cart
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€
3.03
Add to cart